Cargando…

Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy

OBJECTIVE: The purpose of our study is to build nomograms for predicting the possibility of lung metastasis (LM) and bone metastasis (BM) in patients with intrahepatic cholangiocarcinoma (ICC). METHODS: 1527 patients diagnosed with ICC between 2010 and 2016 were collected from the Surveillance, Epid...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ning, Zou, Yiping, Zhang, Yuanpeng, Han, Hongwei, Chen, Zhihong, Ruan, Shiye, Jin, Liang, Ma, Zuyi, Chen, Zhenrong, Lou, Qi, Jin, Haosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725572/
https://www.ncbi.nlm.nih.gov/pubmed/33343665
http://dx.doi.org/10.1155/2020/8889571
_version_ 1783620726955180032
author Shi, Ning
Zou, Yiping
Zhang, Yuanpeng
Han, Hongwei
Chen, Zhihong
Ruan, Shiye
Jin, Liang
Ma, Zuyi
Chen, Zhenrong
Lou, Qi
Jin, Haosheng
author_facet Shi, Ning
Zou, Yiping
Zhang, Yuanpeng
Han, Hongwei
Chen, Zhihong
Ruan, Shiye
Jin, Liang
Ma, Zuyi
Chen, Zhenrong
Lou, Qi
Jin, Haosheng
author_sort Shi, Ning
collection PubMed
description OBJECTIVE: The purpose of our study is to build nomograms for predicting the possibility of lung metastasis (LM) and bone metastasis (BM) in patients with intrahepatic cholangiocarcinoma (ICC). METHODS: 1527 patients diagnosed with ICC between 2010 and 2016 were collected from the Surveillance, Epidemiology, and End Results (SEER) database. Univariable and multivariable logistic regression analyses were used to recognize the predictors of LM and BM, respectively. Then two nomograms were established. We applied the C-index, calibration plot, receiver-operating characteristic (ROC) curve, and decision curve analysis (DCA) to evaluate the novel nomograms. The maximum values of the Youden indexes from the ROC curves were utilized to select the cutoff points of the nomograms. The Kaplan–Meier survival curves were used to evaluate the effect of chemotherapy in different groups. The bootstrap resampling method was chosen for internal validation. RESULTS: Five predictors for LM and three predictors for BM were identified, and two nomograms were constructed. The nomograms had high values of C-indexes, reaching 0.821 (95% CI 0.772–0.871) for LM and 0.759 (95% CI 0.700–0.818) for BM. C-indexes of 0.814 for LM and 0.749 for BM were also observed in internal validation. The calibration plots, ROC curves, and DCAs exhibited favorable performances for predicting LM and BM. The cutoff points of total points in nomograms were 108 for LM and 144 for BM, which could distinguish between high-risk and low-risk groups for LM and BM. Chemotherapy is suggested to undergo for patients in high-risk groups. CONCLUSIONS: The nomograms could assess the possibility of LM and BM in ICC patients and determine the optimal treatment.
format Online
Article
Text
id pubmed-7725572
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-77255722020-12-17 Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy Shi, Ning Zou, Yiping Zhang, Yuanpeng Han, Hongwei Chen, Zhihong Ruan, Shiye Jin, Liang Ma, Zuyi Chen, Zhenrong Lou, Qi Jin, Haosheng J Oncol Research Article OBJECTIVE: The purpose of our study is to build nomograms for predicting the possibility of lung metastasis (LM) and bone metastasis (BM) in patients with intrahepatic cholangiocarcinoma (ICC). METHODS: 1527 patients diagnosed with ICC between 2010 and 2016 were collected from the Surveillance, Epidemiology, and End Results (SEER) database. Univariable and multivariable logistic regression analyses were used to recognize the predictors of LM and BM, respectively. Then two nomograms were established. We applied the C-index, calibration plot, receiver-operating characteristic (ROC) curve, and decision curve analysis (DCA) to evaluate the novel nomograms. The maximum values of the Youden indexes from the ROC curves were utilized to select the cutoff points of the nomograms. The Kaplan–Meier survival curves were used to evaluate the effect of chemotherapy in different groups. The bootstrap resampling method was chosen for internal validation. RESULTS: Five predictors for LM and three predictors for BM were identified, and two nomograms were constructed. The nomograms had high values of C-indexes, reaching 0.821 (95% CI 0.772–0.871) for LM and 0.759 (95% CI 0.700–0.818) for BM. C-indexes of 0.814 for LM and 0.749 for BM were also observed in internal validation. The calibration plots, ROC curves, and DCAs exhibited favorable performances for predicting LM and BM. The cutoff points of total points in nomograms were 108 for LM and 144 for BM, which could distinguish between high-risk and low-risk groups for LM and BM. Chemotherapy is suggested to undergo for patients in high-risk groups. CONCLUSIONS: The nomograms could assess the possibility of LM and BM in ICC patients and determine the optimal treatment. Hindawi 2020-12-02 /pmc/articles/PMC7725572/ /pubmed/33343665 http://dx.doi.org/10.1155/2020/8889571 Text en Copyright © 2020 Ning Shi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shi, Ning
Zou, Yiping
Zhang, Yuanpeng
Han, Hongwei
Chen, Zhihong
Ruan, Shiye
Jin, Liang
Ma, Zuyi
Chen, Zhenrong
Lou, Qi
Jin, Haosheng
Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy
title Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy
title_full Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy
title_fullStr Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy
title_full_unstemmed Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy
title_short Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy
title_sort construction of nomograms for predicting lung and bone metastases in patients with intrahepatic cholangiocarcinoma and identification of patients who can benefit from chemotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725572/
https://www.ncbi.nlm.nih.gov/pubmed/33343665
http://dx.doi.org/10.1155/2020/8889571
work_keys_str_mv AT shining constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT zouyiping constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT zhangyuanpeng constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT hanhongwei constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT chenzhihong constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT ruanshiye constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT jinliang constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT mazuyi constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT chenzhenrong constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT louqi constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy
AT jinhaosheng constructionofnomogramsforpredictinglungandbonemetastasesinpatientswithintrahepaticcholangiocarcinomaandidentificationofpatientswhocanbenefitfromchemotherapy